HKMPY
Price
$53.14
Change
-$1.27 (-2.33%)
Updated
Jul 16 closing price
Capitalization
5.93B
HYPMY
Price
$4.64
Change
-$0.38 (-7.57%)
Updated
Jul 17 closing price
Capitalization
5.79B
Interact to see
Advertisement

HKMPY vs HYPMY

Header iconHKMPY vs HYPMY Comparison
Open Charts HKMPY vs HYPMYBanner chart's image
Hikma Pharmaceuticals
Price$53.14
Change-$1.27 (-2.33%)
Volume$384
Capitalization5.93B
Hypera SA
Price$4.64
Change-$0.38 (-7.57%)
Volume$765
Capitalization5.79B
HKMPY vs HYPMY Comparison Chart in %
Loading...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HKMPY vs. HYPMY commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKMPY is a Hold and HYPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (HKMPY: $53.14 vs. HYPMY: $4.64)
Brand notoriety: HKMPY and HYPMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HKMPY: 45% vs. HYPMY: 1%
Market capitalization -- HKMPY: $5.93B vs. HYPMY: $5.79B
HKMPY [@Pharmaceuticals: Other] is valued at $5.93B. HYPMY’s [@Pharmaceuticals: Other] market capitalization is $5.79B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HKMPY’s FA Score shows that 1 FA rating(s) are green whileHYPMY’s FA Score has 2 green FA rating(s).

  • HKMPY’s FA Score: 1 green, 4 red.
  • HYPMY’s FA Score: 2 green, 3 red.
According to our system of comparison, HYPMY is a better buy in the long-term than HKMPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKMPY’s TA Score shows that 3 TA indicator(s) are bullish while HYPMY’s TA Score has 3 bullish TA indicator(s).

  • HKMPY’s TA Score: 3 bullish, 5 bearish.
  • HYPMY’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, HYPMY is a better buy in the short-term than HKMPY.

Price Growth

HKMPY (@Pharmaceuticals: Other) experienced а -0.49% price change this week, while HYPMY (@Pharmaceuticals: Other) price change was -7.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.97%. For the same industry, the average monthly price growth was +6.36%, and the average quarterly price growth was +73.05%.

Reported Earning Dates

HKMPY is expected to report earnings on Mar 19, 2025.

HYPMY is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.97% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPY($5.93B) and HYPMY($5.79B) have the same market capitalization . HKMPY has higher P/E ratio than HYPMY: HKMPY (32.15) vs HYPMY (15.95). HYPMY YTD gains are higher at: 57.952 vs. HKMPY (8.181). HYPMY has higher annual earnings (EBITDA): 2.86B vs. HKMPY (489M). HYPMY has higher revenues than HKMPY: HYPMY (7.75B) vs HKMPY (2.52B).
HKMPYHYPMYHKMPY / HYPMY
Capitalization5.93B5.79B102%
EBITDA489M2.86B17%
Gain YTD8.18157.95214%
P/E Ratio32.1515.95202%
Revenue2.52B7.75B32%
Total Cash292MN/A-
Total Debt1.28BN/A-
FUNDAMENTALS RATINGS
HKMPY vs HYPMY: Fundamental Ratings
HKMPY
HYPMY
OUTLOOK RATING
1..100
8516
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9279
PRICE GROWTH RATING
1..100
5639
P/E GROWTH RATING
1..100
929
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (14) in the null industry is in the same range as HKMPY (17). This means that HYPMY’s stock grew similarly to HKMPY’s over the last 12 months.

HYPMY's Profit vs Risk Rating (100) in the null industry is in the same range as HKMPY (100). This means that HYPMY’s stock grew similarly to HKMPY’s over the last 12 months.

HYPMY's SMR Rating (79) in the null industry is in the same range as HKMPY (92). This means that HYPMY’s stock grew similarly to HKMPY’s over the last 12 months.

HYPMY's Price Growth Rating (39) in the null industry is in the same range as HKMPY (56). This means that HYPMY’s stock grew similarly to HKMPY’s over the last 12 months.

HYPMY's P/E Growth Rating (9) in the null industry is significantly better than the same rating for HKMPY (92). This means that HYPMY’s stock grew significantly faster than HKMPY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HKMPYHYPMY
RSI
ODDS (%)
Bullish Trend 1 day ago
57%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
74%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 15 days ago
63%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JHML74.250.49
+0.66%
JHancock Multifactor Large Cap ETF
MPRO29.720.10
+0.34%
Monarch ProCap ETF
RZC25.460.08
+0.32%
Reinsurance Group of America
FLMX29.300.04
+0.14%
Franklin FTSE Mexico ETF
ROIS50.12N/A
N/A
Hartford Multifactor International Small Company ETF

HKMPY and

Correlation & Price change

A.I.dvisor tells us that HKMPY and HROW have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPY
1D Price
Change %
HKMPY100%
N/A
HROW - HKMPY
23%
Poorly correlated
+4.60%
PAIOF - HKMPY
22%
Poorly correlated
N/A
CXXIF - HKMPY
22%
Poorly correlated
+8.92%
HYPMY - HKMPY
14%
Poorly correlated
-7.52%
ETST - HKMPY
10%
Poorly correlated
+1.22%
More

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and AYRWF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and AYRWF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
-7.52%
AYRWF - HYPMY
23%
Poorly correlated
+1.29%
PLNH - HYPMY
21%
Poorly correlated
-3.73%
CPIX - HYPMY
20%
Poorly correlated
-4.38%
GLASF - HYPMY
20%
Poorly correlated
+5.58%
KMDA - HYPMY
20%
Poorly correlated
-1.72%
More